The coronavirus SARS-CoV-2 is posing major challenges for healthcare systems and medical institutions worldwide. An ability to rapidly diagnose the virus is of invaluable help in curbing its exponential spread in many countries. Bosch’s new, fully automated rapid test for COVID-19 can help medical facilities such as doctors’ offices, hospitals, laboratories, and health centers make fast diagnoses.
- Bosch CEO Dr. Volkmar Denner: “Bosch’s rapid COVID-19 test will help contain the spread of the pandemic and break the chain of transmission more quickly.”Bosch is helping medical facilities such as doctors’ offices, hospitals, laboratories, and health centers with its new COVID-19 rapid test.
- The rapid test can diagnose ten respiratory pathogens simultaneously for differential diagnosis and meets the requirements of the World Health Organization (WHO).
- Bosch Healthcare Solutions, together with Randox Laboratories Ltd., has developed one of the world’s first fully automated molecular diagnostic tests.
The rapid molecular diagnostic test runs on the Vivalytic analysis device from Bosch Healthcare Solutions. “We want the Bosch rapid COVID-19 test to play a part in containing the coronavirus pandemic as quickly as possible. It will speed up the identification and isolation of infected patients,” says Dr. Volkmar Denner, chairman of the board of management of Robert Bosch GmbH.-MB Bureau